NCT04354246
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04354246
Title COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Compugen Ltd
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Florida Cancer Specialists Sarasota Florida 34230 United States Details
Massachusetts General Hospital. Boston Massachusetts 02114 United States Details
START Midwest. Grand Rapids Michigan 49503 United States Details
The Ohio State University Comprehensive Cancer Center. Columbus Ohio 43210 United States Details
The University of Tennessee WEST Cancer Center. Memphis Tennessee 38138 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
MD Anderson Cancer Center. Houston Texas 77030 United States Details
The START Center for Cancer Care. San Antonio Texas 78229 United States Details
Froedtert & Medical College of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field